Searchable abstracts of presentations at key conferences in endocrinology

ea0105p32 | Poster Presentations | UKINETS2024

Perioperative short-acting somatostatin analogue use in patients undergoing neuroendocrine tumour excision – do we need a change in guidelines?

Bodkhe Komal , Sharma Akshara , Muthusami Anitha , J Ford Samuel

Objective: Neuroendocrine tumours (NETs) are rare tumours and require treatment in specialist centres with familiarity management, particularly mitigation of perioperative risk from carcinoid crisis. This study retrospectively analysed the perioperative management of NET focusing on somatostatin analogue (SSA) utilisation. It aimed to evaluate compliance with local and UKINET guidelines and assess adverse outcomes from non-compliance. UKINET guidelines tailor SSA dosing to tum...